EUVIMEDEUVIMED entdecken
Systematische Übersicht

Radiation Therapy in Alzheimer's Disease: A Systematic Review

David Kaul, Felix Ehret, Siyer Roohani, Marina Jendrach, Maria Buthut, Güliz Acker, Muneeba Anwar, Daniel Zips, Frank Heppner, Harald Prüss

International Journal of Radiation Oncology*Biology*Physics · 2024-05 · 119 (1) · 23-41

DOI: 10.1016/j.ijrobp.2023.11.044 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2024-05. Verfasst von David Kaul und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berl…. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 79 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Pathophysiological hallmarks of Alzheimer's disease (AD) include extracellular amyloid plaques and intracellular neurofibrillary tangles. Recent studies also demonstrated a role of neuroinflammation in the progression of the disease. Clinical trials and animal studies using low-dose radiation therapy (LDRT) have shown therapeutic potential for AD. This systematic review summarizes the current evidence on the use of LDRT for the treatment of AD, outlines potential mechanisms of action, and discusses current challenges in the planning of future trials. METHODS AND MATERIALS: A systematic review of human and animal studies as well as registered clinical trials describing outcomes for RT in the treatment of AD was conducted. We followed the 2020 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Articles published until July 1, 2023, were included. RESULTS: The initial search yielded 993 articles. After the removal of duplicates and ineligible publications, a total of 16 (12 animal, 4 human) studies were included. Various dose regimens were utilized in both animal and human trials. The results revealed that LDRT reduced the number of amyloid plaques and neurofibrillary tangles, and it has a role in the regulation of genes and protein expression involved in the pathological progression of AD. LDRT has demonstrated reduced astro- and microgliosis, anti-inflammatory and neuroprotective effects, and an alleviation of symptoms of cognitive deficits in animal models. Most studies in humans suggested improvements in cognition and behavior. None of the trials or studies described significant (>grade 2) toxicity. CONCLUSIONS: Preclinical studies, animal studies, and early clinical trials in humans have shown a promising role for LDRT in the treatment of AD pathologies, although the underlying mechanisms are yet to be fully explored. Phase I/II/III trials are needed to assess the long-term safety, efficacy, and optimal treatment parameters of LDRT in AD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansAnimalsPlaque, AmyloidNeurofibrillary TanglesClinical Trials as Topic

Autor:innen und Institutionen

  • Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; German Cancer Consortium (DKTK), Partner Site Ber…
  • Department of Neuropathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; German Center for Neurodegenera…
  • Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Department of Neurosurgery, Charité - Universität…
  • Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Zitieren

APA

Kaul, D., Ehret, F., Roohani, S., Jendrach, M., Buthut, M., Acker, G., Anwar, M., Zips, D., Heppner, F., & Prüss, H. (2024). Radiation Therapy in Alzheimer's Disease: A Systematic Review. International Journal of Radiation Oncology*Biology*Physics, 119(1), 23-41. https://doi.org/10.1016/j.ijrobp.2023.11.044

Vancouver

Kaul D, Ehret F, Roohani S, Jendrach M, Buthut M, Acker G, et al. Radiation Therapy in Alzheimer's Disease: A Systematic Review. International Journal of Radiation Oncology*Biology*Physics. 2024;119(1):23-41. doi:10.1016/j.ijrobp.2023.11.044

BibTeX
@article{Kaul2024,
  author = {Kaul, David and Ehret, Felix and Roohani, Siyer and Jendrach, Marina and Buthut, Maria and Acker, Güliz and Anwar, Muneeba and Zips, Daniel and Heppner, Frank and Prüss, Harald},
  title = {Radiation Therapy in Alzheimer's Disease: A Systematic Review},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2024},
  volume = {119},
  number = {1},
  pages = {23--41},
  doi = {10.1016/j.ijrobp.2023.11.044}
}
Kostenlos starten →